Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Medicinal marijuana: Patients battle stigma and misunderstanding

  • CPR: It's not always a lifesaver, but it plays one on TV

  • Goth teens could be more vulnerable to depression and self-harm

  • Brain scans predict response to antipsychotic medications

  • Older adults possess important forms of expertise

  • Covert and overt forms of sexism are equally damaging to working women

  • Retinoids may increase effectiveness of targeted therapies against high-risk leukemia

  • Air pollution linked to children's low academic achievement

  • Turning breath into words: New device unveiled to give paralysis victims a voice

  • Neurobiology: Light-activated learning

  •